Related Experiment Video

Updated: Jul 5, 2026

Adult and Pediatric Porcine Model of Acute Volume Overload
06:09

Adult and Pediatric Porcine Model of Acute Volume Overload

Published on: January 12, 2024

Pediatric obesity in acute and critical care

Andrea M Kline1

  • 1Pediatric Intensive Care Unit, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614, USA. akline@childrensmemorial.org

AACN Advanced Critical Care
|April 18, 2008
PubMed

Insights

Pediatric obesity is a growing epidemic, impacting children's health and leading to serious comorbidities. This review covers obesity trends, its effects on organ systems, and current treatment strategies for children.

Area of Science:

  • Pediatric medicine
  • Public health
  • Endocrinology

Background:

  • Pediatric obesity has reached epidemic levels in the United States.
  • Obesity-related comorbidities are increasingly diagnosed in younger children.
  • These conditions significantly impact the acute and critically ill pediatric population.

Purpose of the Study:

  • To review current epidemiologic trends of pediatric obesity.
  • To examine the multisystem effects of obesity in children.
  • To discuss management strategies for pediatric obesity.

Main Methods:

  • Literature review of recent epidemiologic data on pediatric obesity.
  • Analysis of studies on the impact of obesity on acute and critically ill children.
  • Synthesis of information on nonpharmacologic, pharmacologic, and surgical interventions.

Main Results:

  • Obesity trends show a continued rise in prevalence among children.
  • Obesity negatively affects multiple organ systems, increasing morbidity.
  • Specific data on critically ill children highlight the heightened risks associated with obesity.

Conclusions:

  • Effective strategies are needed to address the pediatric obesity epidemic.
  • Understanding the impact on organ systems is crucial for managing affected children.
  • A comprehensive approach involving various interventions is necessary for combating pediatric obesity.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...